Early Cases
The condition of pulsating exophthalmos was first described in 1809 by Benjamin Travers ( Fig. 2 ; born on April 3, 1783, in Cheapside, London). 47 The patient presented with proptosis, chemosis, and an ocular bruit. When the ipsilateral carotid artery was compressed, the exophthalmos improved and the bruit disappeared. Travers suggested that the condition was confined to the eye and was most likely due to aneurysm of anastomosis of the orbit or intraorbital aneurysm. 47 In 1812, Dalrymple (1772 Dalrymple ( -1947 ) reported a second case of pulsating exophthalmos. 10 Travers' proposed etiology was further supported by Guthrie (1785 Guthrie ( -1856 when he performed the first autopsy on a patient with pulsating exophthalmos in 1923 and observed bilateral large nut-sized aneurysms of the ophthalmic artery. 20, 23, 33 In 1839, Busk (1807 Busk ( -1886 reported findings similar to Guthrie's, and the English school assumed that aneurysm of the ophthalmic artery was the underlying mechanism. 7, 27 In France, however, an autopsy report from Baron in 1835, even prior to Busk's report, showed an abnormal connection between the internal carotid and the cavernous sinus in a patient with pulsating exophthalmos. 3 Unfortunately, his brief report largely escaped the attention of others. The idea of abnormal communication between the cavernous sinus and the carotid artery became recognized as the true source for the constellation of symptoms when Gendrin, Nelaton, and Hirschfeld reported similar autopsy findings in 1841, 1856, and 1857, respectively.
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Furthermore, the autopsy reports demonstrated that the fistula was located intracranially rather than intraorbitally. In 1870, Delens' work on cadavers (Fig. 3) showed that the portion of internal carotid artery traversing the cavernous sinus was most likely to rupture under pressure, which was consistent with the notion of trauma-induced carotid-cavernous sinus fistulas. 15 Rivington and Sattler independently published comprehensive work on the subject in 1875 and 1880, respectively, which helped the etiology of carotid-cavernous fistula gain broader acceptance. 39, 40 In 1935, Walter Edward Dandy (1886-1946) performed postmortem examinations on patients with pulsating exophthalmos and found that abnormal connection between the internal carotid artery and cavernous sinus could be due to an opening, severing of the artery, or weakening of the wall by arteriosclerosis.
11,12

Treatment
Treatment for CCF has been refined over the years. The Hunterian ligation technique was popularized in the 1800s to treat arterial aneurysms. In December 1785, John Hunter (1728-1793) treated a popliteal aneurysm in a young man by ligating the feeding femoral artery. 9, 45 Although the artery ruptured 5 days after ligation, Hunter demonstrated that occlusion of the artery proximal to the aneurysm was a possible treatment option. Hunter would go on to improve the technique and in the words of his colleague, "…the plan conceived for the cure of popliteal aneurysms; which discovery will form an eternal monument of glory to its author." 41, 42 Although the technique was referred to as Hunterian ligation, Dominique Anel was arguably the true father of the technique. 36, 45 In 1808, Astley Cooper, Hunter's former student, attempted to treat a cervical aneurysm by ligating the common carotid artery, but the patient died of sepsis 3 weeks later. plied the techniques he had learned and performed ligation of the common carotid artery in a 28-year-old female with unilateral pulsating exophthalmos; this became the first documented surgical treatment of CCF. 27, 47 Over the next century, carotid artery ligation was the treatment of choice for CCF. However, high morbidity and mortality, dangers of hemiplegia, and fistula recurrence necessitated further refinement. 14, 16, 17 In 1851, Brainard (1812-1866), professor of surgery at Rush Medical College, cured a case of pulsating exophthalmos by injecting a coagulating fluid into the dilated orbital veins; however, the patient developed vision loss in the affected eye. 4, 27 In 1856, Professor Gioppi was the first to recommend digital compression (Fig. 4) . 18 Digital compression had been helpful in determining the extent of compression required to obliterate the fistula communication and candidacy for ligation, thus it was highly recommended prior to ligation operations. However, Raaf, Swan, and Locke warned against chronic daily compression protocols, which might actually increase circulation through the anastomosis and negatively impact subsequent ligation success. 27, 38 Noland reported a more conservative treatment approach-bed rest and compression of the eyeball, but this resulted in vision loss of the affected eye. 6, 32 Lansdown was the first to successfully perform orbital vein ligation for pulsating exophthalmos in 1874, 26 and this remained an alternative treatment method when other procedures failed. tery, as opposed to the traditional common carotid artery approach, for the treatment of CCF. 31 However, Locke's comprehensive review of 588 cases showed that the results from internal carotid artery ligation were similar to the reported outcomes of common carotid artery ligation approaches. Moreover, Locke's careful autopsy work showed that direct fistula connection between the carotid artery and cavernous sinus was the main cause of traumatic CCF, whereas tumor, internal carotid artery aneurysm, and ophthalmic artery aneurysm etiologies accounted for a significant proportion of spontaneous CCF cases. 27 In 1939, Walter Dandy published the first report of intracranial internal carotid artery clipping as a treatment for CCF (Fig. 5) . 13 The goal was to induce thrombosis within the lesion, leading to obliteration of the fistula. The procedure was carried out in patients who had been treated but not cured by extracranial carotid artery ligation and in whom the CCF was consequently trapped between the carotid ligature and the intracranial clip. 13 In the article, Dandy states:
An ordinary flat silver clip was placed over the neck of the sac and tightly compressed, obliterating it completely. The clip was flush with the wall of the carotid artery. The sac, lateral to the silver clip, was then picked up with the forceps and thrombosed by the electrocautery. It shriveled to a thin shred of tissue. It is worthy of note that the aneurysm became much softer after the silver clip had been applied; it also ceased to pulsate…. 13 In 1964, Hamby advocated for a more aggressive approach-intracranial suture ligation of the supraclinoid internal carotid artery. 22 Subsequently, Hamby and Gardner incorporated "Barney Brooks' embolization technique," in which a flow-directed muscle embolus is introduced through the cervical internal carotid artery to occlude the CCF following carotid artery ligation. 22 The "Brooks' method," however, is a misinterpretation by Hamby and Gardner, as Brooks never described the successful use of a muscle embolus to occlude a CCF with resulting cure of pulsating exophthalmos. As Brooks stated in his discussion to the Noland and Taylor paper, "Pulsating exophthalmos, the result of injury": "Owing to the curvature of the bony canal through which the carotid artery enters the intracranial cavity, it is difficult to be sure that our attempt to obliterate the artery at the site of the fistulous opening was successful." 6 Hamby also believed that carotid-cavernous fistulas should be targeted directly like fistulas of the extremities rather than targeting the feeding arteries.
22 As Hamby stated: "As in other parts of the body the fistula itself should be attacked rather than attempting piecemeal progressive ligation of its feeding arteries."
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Nevertheless, the lack of understanding of the cavernous sinus anatomical architecture in relation to the carotid artery made interventions difficult prior to the 1970s. The cavernous sinus was named by James Winslow in 1734 and was thought of as a large trabeculated venous cavern that completely surrounds the carotid artery, containing within it the third, fourth, and sixth cranial nerves as well as the V1 and V2 branches of the fifth cranial nerve. 17, 49 Venous corrosion specimen work by Parkinson from the 1960s and 1970s showed that cavernous sinus was neither a true sinus nor cavernous, but rather it was an irregular venous plexus traveling around the carotid artery. 34, 35 This meant that surgeons could target the fistula directly without affecting the arterial and venous channels. In 1973, Parkinson reported 2 cases involving the successful use of a direct surgical approach that preserved the carotid artery, 34 but the difficulty and precision of the procedure prevented it from being widely adopted. Parkinson stated in his paper: "The neurosurgeon is therefore required to make a rapid excursion through the tightly packed tangle of abnormally dilated, thickened, adherent veins to the underlying arterial wall as he dissects his way to the fistula."
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Fedor Serbinenko (born May 24, 1928 , in Dmitriovsk in the former Soviet Union) completely changed the field of neurosurgery as he ushered in a new era of endovascular neurosurgery with the invention of the balloon catheter, which some people say was inspired by helium balloons that Serbinenko saw at the 1959 May Day celebration in Moscow's Red Square. 46 The initial iterations of the bal- loon catheter were nondetachable and were primarily used by Serbinenko to aid in the diagnosis of major cerebral artery occlusions. 46 In 1971, Prolo and Hanbery first attempted occlusion of a CCF using a nondetachable balloon, but the internal carotid artery was sacrificed as part of the procedure. 37 Serbinenko subsequently modified his balloon catheter design with a valve mechanism that allowed the balloon to be detached from the catheter (Fig.  6 ). In 1974, Serbinenko and colleagues were the first group to successfully treat CCF by occlusion using a detachable balloon catheter while preserving the internal carotid artery. 43 Due to the Cold War, there was little exchange of scientific and medical knowledge between Russia and the Western world, and it took some time before Serbinenko's technique was adopted. 50 Serbinenko was truly pivotal in the pioneering of endovascular neurosurgery.
As Serbinenko was working on perfecting the balloon catheter in the former Soviet Union, John F. (Sean) Mullan (1925 Mullan ( -2015 was pioneering minimally invasive endovascular approaches at the University of Chicago. In 1974, he published his experiences of using thrombogenic techniques, such as direct current electrical thrombosis, stereotaxic copper electric needle thrombosis, and intracavernous thrombogenic wires, to treat CCF. According to his results, intracavernous wire thrombosis led to the better outcome as it preserved carotid flow. 28 In a subsequent 1979 paper, Mullan recommended retrograde packing of the cavernous sinus, transjugular insertion of an occluding balloon, and thrombogenic wire and needles. 29 Mullan was one of the first to emphasize the importance of intraoperative angiography during endovascular neurosurgery. Currently, transarterial and transvenous embolization with detachable metallic coils or liquid embolic agents (Nbutyl-2-cyanoacrylate or Onyx) is the primary treatment approach for CCF in the US. 2, 21, 25, 51 Drawbacks include cost and potential occlusion of important veins draining into the cavernous sinus. 5 Similar to balloons, the coils may cause cranial nerve palsy. More recently, endovascular stent-grafts have been shown by Weber et al., 48 Gomez et al., 19 Archondakis et al., 1 and Choi et al. 8 to be an attractive alternative treatment for CCFs. The covered stent approach preserves parent artery blood flow and eliminates the risks of pseudoaneurysm formation and device rupture. 24, 44 Although a promising technique, the covered stents need to be made more flexible so they can be easily navigated through the tortuous intracranial vessels.
Conclusions
Treatment of CCF has come a long way since Travers' first surgical ligation procedure and external carotid compression by a crude wooden apparatus (Fig. 4) . 27 The high morbidity and mortality associated with historical CCF treatments has been dramatically reduced with modern endovascular approaches. 17 With continuing advances in medical and endovascular technology, such as polytetrafluoroethylene-covered stents, the outcomes of CCF treatment will continue to improve. 
